MRK vs. CRWV
MRK (Merck & Co., Inc.) and CRWV (CoreWeave, Inc.) are both stocks. MRK operates in Drug Manufacturers - General (Healthcare), while CRWV operates in Software - Infrastructure (Technology). Over the past year, MRK returned 56.85% vs -26.96% for CRWV. At a correlation of -0.04, they often move in opposite directions.
Performance
MRK vs. CRWV - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, MRK achieves a 14.39% return, which is significantly lower than CRWV's 42.95% return.
MRK
- 1D
- -1.05%
- 1M
- 7.31%
- YTD
- 14.39%
- 6M
- 22.75%
- 1Y
- 56.85%
- 3Y*
- 5.78%
- 5Y*
- 13.57%
- 10Y*
- 11.61%
CRWV
- 1D
- 1.97%
- 1M
- -10.32%
- YTD
- 42.95%
- 6M
- 18.70%
- 1Y
- -26.96%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
MRK vs. CRWV - Yearly Performance Comparison
| 2026 (YTD) | 2025 | |
|---|---|---|
MRK Merck & Co., Inc. | 14.39% | 23.61% |
CRWV CoreWeave, Inc. | 42.95% | 83.62% |
Correlation
The correlation between MRK and CRWV is -0.09, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | -0.09 |
Correlation (All Time) Calculated using the full available price history since Mar 28, 2025 | -0.04 |
Fundamentals
MRK:
$295.45B
CRWV:
$53.95B
MRK:
$3.58
CRWV:
-$3.27
MRK:
4.54
CRWV:
8.00
MRK:
6.44
CRWV:
11.34
MRK:
$65.59B
CRWV:
$6.23B
MRK:
$49.79B
CRWV:
$4.32B
MRK:
$22.69B
CRWV:
$1.89B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
MRK vs. CRWV — Risk / Return Rank
MRK
CRWV
MRK vs. CRWV - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Merck & Co., Inc. (MRK) and CoreWeave, Inc. (CRWV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| MRK | CRWV | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +2.38 | ||
| Sortino ratioReturn per unit of downside risk | +2.83 | ||
| Omega ratioGain probability vs. loss probability | 1.36 | 1.02 | +0.34 |
| Calmar ratioReturn relative to maximum drawdown | 5.03 | -0.42 | +5.44 |
| Martin ratioReturn relative to average drawdown | 12.59 | -0.62 | +13.21 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| MRK | CRWV | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 2.10 | -0.28 | +2.38 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.58 | — | — |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.51 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.48 | 1.06 | -0.57 |
Drawdowns
MRK vs. CRWV - Drawdown Comparison
The maximum MRK drawdown since its inception was -68.61%, which is greater than CRWV's maximum drawdown of -64.84%. Use the drawdown chart below to compare losses from any high point for MRK and CRWV.
Loading charts...
Drawdown Indicators
| MRK | CRWV | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -68.61% | -64.84% | -3.77% |
Max Drawdown (1Y)Largest decline over 1 year | -11.37% | -64.84% | +53.47% |
Max Drawdown (3Y)Largest decline over 3 years | -43.44% | — | — |
Max Drawdown (5Y)Largest decline over 5 years | -43.44% | — | — |
Max Drawdown (10Y)Largest decline over 10 years | -43.44% | — | — |
Current DrawdownCurrent decline from peak | -4.65% | -44.24% | +39.59% |
Average DrawdownAverage peak-to-trough decline | -18.84% | -37.21% | +18.37% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.53% | 43.73% | -39.20% |
Volatility
MRK vs. CRWV - Volatility Comparison
The current volatility for Merck & Co., Inc. (MRK) is 9.44%, while CoreWeave, Inc. (CRWV) has a volatility of 25.28%. This indicates that MRK experiences smaller price fluctuations and is considered to be less risky than CRWV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| MRK | CRWV | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 9.44% | 25.28% | -15.84% |
Volatility (6M)Calculated over the trailing 6-month period | 18.14% | 68.15% | -50.01% |
Volatility (1Y)Calculated over the trailing 1-year period | 27.30% | 95.71% | -68.41% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 23.71% | 114.59% | -90.88% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 22.96% | 114.59% | -91.63% |
Dividends
MRK vs. CRWV - Dividend Comparison
MRK's dividend yield for the trailing twelve months is around 2.78%, while CRWV has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CRWV CoreWeave, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
MRK Merck & Co., Inc. | 2.78% | 3.12% | 3.14% | 2.72% | 2.52% | 3.41% | 3.03% | 2.48% | 2.60% | 3.36% | 3.14% | 3.43% |
Financials
MRK vs. CRWV - Financials Comparison
This section allows you to compare key financial metrics between Merck & Co., Inc. and CoreWeave, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
MRK vs. CRWV - Profitability Comparison
MRK - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Merck & Co., Inc. reported a gross profit of 13.34B and revenue of 16.29B. Therefore, the gross margin over that period was 81.9%.
CRWV - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, CoreWeave, Inc. reported a gross profit of 1.36B and revenue of 2.08B. Therefore, the gross margin over that period was 65.5%.
MRK - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Merck & Co., Inc. reported an operating income of -1.88B and revenue of 16.29B, resulting in an operating margin of -11.6%.
CRWV - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, CoreWeave, Inc. reported an operating income of -144.00M and revenue of 2.08B, resulting in an operating margin of -6.9%.
MRK - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Merck & Co., Inc. reported a net income of -4.24B and revenue of 16.29B, resulting in a net margin of -26.0%.
CRWV - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, CoreWeave, Inc. reported a net income of -740.00M and revenue of 2.08B, resulting in a net margin of -35.6%.
Frequently Asked Questions
MRK and CRWV have a correlation of -0.09, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
CRWV has higher volatility (25.28%) compared to MRK (9.44%). In terms of maximum drawdown, MRK dropped -68.61% vs CRWV's -64.84%.
MRK currently has the higher Sharpe Ratio (2.10 vs -0.28), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for MRK and CRWV
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer